Syngene International
SYNGENE
Quick Bite
Price To Earnings Ratio 67.56 | Sector PE 65.43 |
PB Ratio 8.23 | Sector PB 8.93 |
EPS 12.69 | Dividend Yield 0.18 |
Today's Volume 141.640 K | 5 Day Avg. Volume 272.779 K |
PEG Ratio 6.99 | Market Cap. ₹ 34,570.00 Cr. |
Returns Comparison
| Time | SYNGENE | VS | Industry |
|---|---|---|---|
| 1 Day | 2.29% | 1.42% | |
| 1 Week | 0.34% | 1.36% | |
| 1 Month | 3.89% | -0.56% | |
| 6 Months | 31.97% | 14.7% | |
| 1 Year | 27.3% | 46.06% |
Technical Trend
Pivot Levels
Moving Averages
| Period (Days) | SMA | Indication |
|---|---|---|
| 10 | 859.02 | Bearish |
| 20 | 858.09 | Bearish |
| 30 | 857.71 | Bearish |
| 50 | 866.99 | Bearish |
| 100 | 824.86 | Bullish |
| 200 | 739.07 | Bullish |
Shareholding Updates
Cash Flow
| Annual | FY 2024 | FY 2023 | FY 2022 | ||||
|---|---|---|---|---|---|---|---|
| Operating Activities | 1042.10 | 823.50 | 580.60 | ||||
| Investing Activities | -495.60 | -656.40 | -611.50 | ||||
| Financing Activities | -551.40 | -342.50 | -31.30 | ||||
| Net Cash Flow | -4.90 | -175.40 | -62.20 |
All Figures in ₹ Cr., unless mentioned otherwise
Ratios
Income Statement
Balance Sheet
Peer Comparison
| Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
|---|---|---|---|---|---|
| Syngene International | 2.29 | 0.34 | 3.89 | 31.97 | 27.3 |
| Aarti Drugs | -1.1 | -3.17 | -6.83 | -2.53 | 2.88 |
| Abbott India | 2.2 | 0.61 | -3.67 | 3.31 | 20.57 |
| Advanced Enzyme Tech | -1.69 | -2.78 | -16.05 | -7.08 | 13.34 |
| Ajanta Pharmaceuticals | 1.18 | 5.73 | 2.08 | 13.83 | 47.7 |
About Syngene International
Syngene International Share Price
Syngene International Limited is an integrated research, development and manufacturing service company operating in India. The company provides contract research and manufacturing services from lead generation to clinical supply to pharmaceutical and biotechnology companies worldwide. Its services include drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process research and development, current good manufacturing practice (cGMP) production, formulation and analytical development, and clinical development services. It offers SynVent, a therapeutic discovery and development platform for drug development projects. SynVent's portfolio spans categories and therapeutic areas from small molecule inhibitors to targeted protein stabilisation. It serves the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries.
Syngene International FAQs
How to Buy Syngene International Share?
What's Syngene International share price today?
What is the Market Cap of Syngene International?
What is the PE and PB ratio of Syngene International?
What is the 52 Week High and Low of Syngene International Share?